Packing foam in sheet form

Courier services

Electronic signature application, association, authorization and verification services; computer services in relation to electronic signature application, association, verification and authorization services; Software-as-a-Service (SaaS) for signing and sending electronic documents; Software-as-a-Service (SaaS) for generating, encrypting, decrypting, obtaining, managing, capturing, storing, processing, and viewing the following: electronic signatures, electronic signature data, encrypted and unencrypted records that may be or have been signed with an electronic signature, and electronic association information between electronic signatures and electronic records; associating encrypted, unencrypted, and decrypted records with electronic signature data and encryption and communication of records associated with electronic signatures; software as a service (SaaS) featuring software for the application and logical association of electronic signatures in association with electronic records, for verifying authenticity of previously applied or associated electronic signatures on electronic records, for applying and requesting the application of electronic signatures on encrypted and unencrypted electronic records, and sending encrypted electronic records over communications networks; electronic document time-stamping services; digital signature verification services; monitoring of electronic access to encrypted and unencrypted electronic records; software as a service (SaaS) service featuring software and online services for sending electronic signature requests, completing contracts, recording acknowledgments, electronically signing documents, tracking multi-signatory documents in real-time, and associating electronic signatures with encrypted electronic records that are unencrypted for signature.

Fraud prevention services relating to electronic commerce, namely tamper proofing and integrity validation of electronic information.

Access-auditing and modification-auditing services for encrypted information; automated access-revocation, access-expiration, deletion, and return services for encrypted information; encryption key security and access-management services for encrypted information; encryption user key repair; and real-time management by a supervisor of multi-user access-rights for encrypted information.

Nanoparticle substances namely, chemical compositions and biochemical preparations in the form of silicon, lipid and hybrid silicon-lipid nanoparticles for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals and vaccines; Nanoparticle substances namely, chemical compositions and biochemical preparations in the form of silicon, lipid and hybrid silicon-lipid nanoparticles for use as stabilizing agents, active pharmaceutical ingredients, drug delivery molecules, carrier substances and buffer compounds, all for use in the development, formulation and manufacture of pharmaceuticals and biopharmaceuticals and vaccines; Silicon namely, silicon nanoparticles for use in industry, science and research; silicon for use in industry, science and research; silicon nanoparticle materials for use in industry, science and research; porous silicon nanoparticle materials for use in industry, science and research; lipid nanoparticles for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon-lipid nanoparticles for use in industry, science and research; silicon-stabilised hybrid lipid nanoparticles for use in industry, science and research; silicon-stabilised lipid nanoparticles for use in industry, science and research; stabilised lipid nanoparticles for use in industry, science and research; nanoparticles for carrying and delivery of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; porous silicon nanoparticles for carrying and delivery of chemical, biochemical and biological substances; lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in gene therapy; nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon¬ stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; nanoparticles for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances; porous silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances; lipid nanoparticles for stabilising of chemical, biochemical and biological substances; silicon-lipid nanoparticle materials for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; silicon-stabilised lipid nanoparticles for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; stabilised lipid nanoparticles for stabilising of chemical, biochemical and biological substances used in the manufacture of pharmaceuticals, biopharmaceuticals and vaccines; nanoparticles for stabilising nucleic acids; silicon nanoparticle materials for stabilising nucleic acids; porous silicon nanoparticle materials for stabilising nucleic acids; lipid nanoparticles for stabilising nucleic acids; silicon-lipid nanoparticle materials for stabilising nucleic acids; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acids; silicon-stabilised lipid nanoparticles for stabilising nucleic acids; nanoparticles for stabilising nucleic acid-lipid complexes; silicon nanoparticle materials for stabilising nucleic acid-lipid complexes; porous silicon nanoparticle materials for stabilising of nucleic acid-lipid complexes; lipid nanoparticles for stabilising nucleic acid-lipid complexes; silicon-lipid nanoparticle materials for stabilising nucleic acid-lipid complexes; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acid-lipid complexes; silicon-stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexes.

Drug delivery agents in the form of nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of silicon nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of porous silicon nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of lipid nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of silicon-lipid hybrid nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; drug delivery agents in the form of nano-capsules and micro-capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals for human and veterinary purposes; Silicon nanoparticles for medical, veterinary and pharmaceutical research purposes; porous silicon nanoparticles for medical, veterinary and pharmaceutical research purposes; lipid nanoparticles for medical, veterinary and pharmaceutical research purposes; silicon-lipid hybrid nanoparticles for medical, veterinary and pharmaceutical research purposes; Stabilizing agents for vaccines for humans and for animals; Stabilizing agents for nucleic acids; silicon nanoparticles for stabilizing nucleic acids, silicon nanoparticles for stabilizing nucleic acids; porous silicon nanoparticles for stabilizing nucleic acids, lipid nanoparticles for stabilizing nucleic acids, silicon-lipid hybrid nanoparticles for stabilizing nucleic acids; Stabilizing agents for nucleic acid-lipid complexes; silicon nanoparticles for stabilizing nucleic acid-lipid complexes, silicon nanoparticles for stabilizing nucleic acid-lipid complexes; porous silicon nanoparticles for stabilizing nucleic acid-lipid complexes, lipid nanoparticles for stabilizing nucleic acid-lipid complexes, silicon-lipid hybrid nanoparticles for stabilizing nucleic acid-lipid complexes; Transfection agents for nucleic acids; Silicon nanoparticles for controlled release of nucleic acids; porous silicon nanoparticles for controlled release of nucleic acids; lipid nanoparticles for controlled release of nucleic acids; silicon-lipid hybrid nanoparticles for controlled release of nucleic acids.

Courier services

Transportation brokerage services, namely arranging for the transportation of third-party goods, documents, packages, and freight; Transportation services, namely pick-up, transportation, delivery, tracking, and storage of third-party goods, documents, package,s and freight by foot courier, bike courier, air, rail, ship, or truck; Freight transportation brokerage; Freight forwarding services; Freight handling, loading, and unloading services; Parcel delivery; Courier services; Customs brokerage; Insurance services, namely arranging for the insurance of goods of others during transport; Supply chain logistics and reverse logistics services consisting of the delivery of goods for others by foot courier, bike courier, air, rail, ship or truck; Supply chain logistics and reverse logistics services consisting of the storage of goods for others by foot courier, bike courier, air, rail, ship or truck; Warehouse storage services, including storage of the goods, documents, packages, and freight of others; Leasing storage space for storage of third-party goods, documents, packages, and freight; Packing, crating, and warehousing services; Distribution of advertising material for others; Distribution of the goods and merchandise of others; Consulting and advisory services in the field of shipping.

Courier services

Courier services; providing an online portal to coordinate the delivery of packages for others; coordinating the delivery of packages for others; providing mobile application software for coordinating and obtaining package delivery services.

Courier services; delivery of goods by truck; messenger services.

Office functions, namely, computerized tracking and tracing of documents, packages and freight; customs clearance services; business management of customs brokers; tracking and monitoring import insurance compliance for business purposes; Supply chain logistics services, namely, storage, transportation and delivery of documents, packages, investigational drugs, drug samples, active pharmaceutical ingredients, drug excipients, commercial products, and other freight for others all by air, rail, ship or truck; import cargo handling services